Inhibition of HIV infection by the cytokine midkine

Virology

Volumn 281, Issue 2, 2001, Pages 248-264

  Callebaut, Christian ^a   Nisole, Sébastien ^a   Briand, Jean Paul ^b   Krust, Bernard ^a   Hovanessian, Ara G ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; HEPARAN SULFATE; INTERLEUKIN 2; MESSENGER RNA; MIDKINE; NUCLEOLIN;

ANTIVIRAL ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG BINDING; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; PARACRINE SIGNALING; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035866661     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0767     Document Type: Article

References (47)

1. CD28 costimulation increases CD8+ cell suppression of HIV replication
2. HIV entry and tropism: The chemokine receptor connection
3. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy
4. + cells
5. +T cells expressing relatively high levels of CD26
6. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death
7. Pseudopeptides TASP inhibitors of HIV infection block viral entry by binding to a 95 kDa cell surface protein
8. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1 infected patients receiving highly active anti-retroviral therapy
9. Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production
10. The mode and duration of anti-CD28 co-stimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro
11. Internalization of anti-nucleolin antibody into viable HEp-2 cells
12. Tumor formation dependent on proteoglycan biosynthesis
13. Interferons in the persistence, pathogenesis, and treatment of HIV infection
14. Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals
15. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion
16. IL-2-Dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control
17. Solution structure of midkine, a new heparin-binding growth factor
18. Inhibition of entry of HIV in cells by poly(A) · poly(U)
19. Midkine binds specifically to sulfatide: The role of sulfatide in cell attachment to midkine-coated surface
20. Pleiotrophin and midkine in normal development and tumor biology
21. Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5
22. Cell surface expression of several species of human immunodeficiency virus type 1 major core protein
23. CD3- and CD28-dependent induction of PDE7 required for T cell activation
24. Th1 and Th2 cells in HIV infection
25. Cytosolic Gag p24 as an index of productive human immunodeficiency virus type 1 entry
26. Human immunodeficiency virus type 1 attachment to Hela CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
27. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
28. The midkine family of growth/differentiation factors
29. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface expressed nucleolin independent of heparan sulfate proteoglycans
30. 2N)PR]-TASP inhibits attachment of T-lymphocyte- and macrophage-tropic HIV to permissive cells
31. β-chemokines inhibition of monocytotropic HIV-1 infection. Interference with a post-binding fusion step
32. Immune hyperactivation of HIV-1 infected T cells mediated by Tat and the CD28 pathway
33. The immunopathogenesis of human immunodeficiency virus infection
34. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM)
35. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
36. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
37. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
38. 2N)PR]-TASP inhibits HIV infection in primary macrophage cultures
39. Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM)
40. HIV-1 attachment: Another look
41. Neutralizing antibodies against the V3 loop of the HIV-1 gp120 block the CD4-dependent and independent binding of virus to cells
42. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
43. Negative regulation of cytokine gene transcription
44. The interleukin-2 fusion protein, DAB3891L-2, inhibits the development of infectious virus in human immunodeficiency virus type 1-infected human peripheral blood mononuclear cells
45. Human CD4+ cells transfected with IL-16cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression
46. A heparin-binding growth factor, midkine, binds to chondroitin sulfate proteoglycan, PG-M/versican
47. Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2